Related Experiment Video
Updated: Dec 10, 2025
05:06
A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
12.6K
Study on the hepatocellular carcinoma model with metastasis
Yu-Lin Lin1, Yan Li1
1Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China.
Genes & Diseases
|September 5, 2020
Summary
Developing hepatocellular carcinoma (HCC) models with stable metastatic potential is crucial for understanding cancer spread. This review details the evolution of HCC models, focusing on metastasis and recurrence mechanisms.
Area of Science:
- Oncology
- Cancer Biology
- Translational Medicine
Background:
- Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality globally.
- Late diagnosis, recurrence, and metastasis contribute to poor outcomes.
- Existing animal models often fail to replicate human HCC invasion and metastasis.
Purpose of the Study:
- To review the historical development of HCC animal and cell models.
- To focus on methods for screening and maintaining metastatic potential in HCC models.
- To highlight the importance of stable metastatic phenotypes for research.
Main Methods:
- Literature review of HCC models over the past three decades.
- Analysis of studies focusing on metastasis and recurrence mechanisms.
- Examination of techniques for establishing and validating metastatic HCC models.
Main Results:
- Significant progress has been made in developing HCC models with stable metastatic phenotypes.
- These models have facilitated deeper understanding of HCC metastasis.
- Established models aid in exploring therapeutic strategies for HCC metastasis and recurrence.
Conclusions:
- Advanced HCC models are essential for dissecting metastasis and recurrence.
- Continued development of reliable models is critical for therapeutic breakthroughs.
- Understanding metastasis biology through robust models drives innovation in HCC treatment.
